130. Psilocybin and Menopause: Two Clinicians Reframe Midlife for Women

Episode Summary

Estrogen regulates the serotonin system, and psilocybin reaches the same receptor. That is where this Salon starts, and it is the most specific version of the psilocybin and menopause conversation I have heard in public.

Kelly McGinty, a nurse practitioner, told a full room at Town Hall Seattle that the drop women feel in perimenopause is physiological rather than imagined. I asked whether that means psilocybin replaces estrogen. She said no, and that she would like more research. Her co-author, Dr. Trish Singh, added that research on menopausal women barely exists at any phase of the transition.

Two clinicians describe what they see in their patients, then draw a line at the point where the evidence ends. Most people selling a reframe of midlife will not draw that line on a microphone.

What sits on the other side of it: anxiety as a knock on the door rather than a malfunction, why women microdose intuitively instead of on a protocol, and the archetypes we inherit about aging women. Kelly's oldest client is 85, and she says the younger generation is watching to see how the older one heals.

A woman in perimenopause deserves an explanation for what is happening in her body. Psilocybin is not what delivers that. A provider who knows the full symptom list is.

🔵 Timestamps

0:00 Introduction

2:15 Why these clinicians reframe menopause as a rite of passage

6:20 Estrogen, serotonin, and what psilocybin cannot replace

10:10 Anxiety and brain fog in perimenopause

14:55 Why women microdose intuitively instead of on a protocol

18:10 What the microdosing research actually shows

19:20 Consciousness, unnaming, and identity in midlife

21:35 Ending the shame around menopause

24:25 The FDA hormone therapy warning change, explained

25:30 Goddess, crone, and the archetypes of aging women

30:35 Elders, psychedelics, and the wellness industry problem

🔵 Guests

Kelly McGinty, C-FNP, MSN is a family nurse practitioner accredited by the American Academy of Nurse Practitioners, with a master's in nursing from Gonzaga University. She spent more than a decade as an emergency department NP before training in psychedelic-assisted psychotherapy at the California Institute of Integral Studies, and she now works with first responders, people at end of life, and patients with treatment-resistant conditions. She is the clinician in this conversation who names the physiology and then names its limits. Kelly's website

Dr. Trish Singh, PhD, LPCC is a licensed mental health counselor in New Mexico and California with twenty-five years in behavioral health. Her doctorate is in mind-body medicine with a specialization in integrative mental health, she is certified in psychedelic-assisted therapy through CIIS, and she founded A New Awakening Counseling, which serves people reentering society after incarceration. Her current research is on holistic weight strategies for menopausal women, and she is the reason this episode ends up talking about archetypes rather than symptoms. Trish's website

Together they co-authored Mycelopause: Uncovering the Magic of Menopause with Psilocybin.

Original Substack post: ⁠⁠https://aprilpride.substack.com/psilocybin-and-perimenopause

🔵 Resources

Psychedelic Salon at Town Hall Seattle - ⁠2026-27 Schedule⁠

⁠⁠SetSet Psychedelic Cards⁠⁠

⁠⁠Women in the Wild application⁠⁠

The Next Chapter virtual live screening - RSVP here

More about Mycelopause on Substack + Instagram

Hosted by April Pride

Subscribe for April’s newsletter on Substack at ⁠⁠https://aprilpride.substack.com/subscribe⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Follow on IG: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@aprilpridecreates⁠ / YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠youtube.com/@aprilpridecreates ⁠

Get full access to APRIL PRIDE at ⁠aprilpride.com⁠

129. Psychedelics for Seniors: Aging & What's Next

Episode Summary

The psychedelic renaissance gets covered like a young person's story: executives microdosing before board meetings, twenty-somethings on retreats. But the fastest-growing population interested in this medicine right now is confronting retirement, widowhood, the death of parents, the question of legacy. This episode is a live Salon recording built around psychedelics for seniors, with filmmaker Scott Paul Wright, writer Abbie Rosner, and naturopathic physician Dr. Emily Whinkin. We get into set and setting, medication contraindications, ketamine versus psilocybin, and what integration actually looks like once the journey is over. Abbie's research on 36 older adults turns up something worth sitting with: most of them called later life the happiest, most meaningful stretch they've had.

🔵 Key Takeaways

Set and setting, not age, is the biggest predictor of a safe psychedelic experience. Older adults often prepare better than younger users because they're less inclined to wing it.

If you're on an SSRI or SNRI, expect a blunted psychedelic experience. The evidence on whether that blunting reduces therapeutic benefit is still mixed.

Ketamine and psilocybin are distinct molecules with different legal statuses and safety histories. Neither is automatically the safer choice for an older nervous system.

Integration circles are the antidote to isolation, which among older adults carries measurable health costs, including a documented rise in dementia risk.

The questions shift with age. Younger clients tend to ask what can I fix. Older clients tend to ask what my legacy is and how I can give back.

🔵 Timestamps

[00:00] Welcome and introductions at Town Hall Seattle [00:01] Scott Wright on his first journey at 68 and how the documentary began [00:02] Why older adults report fewer bad trips: preparation and set and setting [00:04] Contraindications, health history, and working with SSRIs and SNRIs [00:06] Ketamine versus psilocybin: different molecules, different legal paths [00:08] Meaning making in later life and what psychedelics surface [00:10] What integration actually is, and why the work starts after the journey [00:13] Integration circles as community and clinical infrastructure [00:17] The questions older adults ask that younger clients don't [00:18] Aging, elderhood, and the Buddhist "three messengers" [00:20] Intergenerational journeys and psychedelics within families

🔵 Guest

Abbie Rosner is a writer and cultural observer exploring how the modern psychedelic renaissance is reshaping our understanding of aging—individually and collectively. Psychedelics and the Counter Culture of Aging | website ELDEREVOLUTION on Substack

Dr. Emily Whinkin (she/they) is a naturopathic physician and integrative mental health specialist blending psychedelic and entheogenic medicine with mental, reproductive, and generative health. Dr. Whinkin is licensed in Oregon and Washington, provides global consultation, and is dedicated to research, education, and individualized integrative mental health. emilywhinkin.com

Scott Paul Wright is a filmmaker and screenwriter based in Paris and New Orleans. He took his first psychedelic journey at age 68 – resulting in his new documentary – The Next Chapter, which is now in post-production and scheduled for release in June 2026. The Next Chapter documentary

Original Substack post: ⁠https://aprilpride.substack.com/psychedelics-for-seniors-aging-salon

🔵 Resources

Psychedelic Salon at Town Hall Seattle - 2026-27 Schedule

⁠SetSet Psychedelic Cards⁠

⁠Women in the Wild application⁠

Hosted by April Pride

Subscribe for April’s newsletter on Substack at ⁠https://aprilpride.substack.com/subscribe⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Follow on IG: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@aprilpridecreates / YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠youtube.com/@aprilpridecreates ⁠

Get full access to APRIL PRIDE at ⁠aprilpride.com⁠

128. Ancestral Trauma & Psychedelic Integration

A 45-year psychedelic guide on ancestral trauma, Internal Family Systems, and why integration, not the ceremony, is the real medicine.

Episode Summary

Most conversations about psychedelics stay at the level of the ceremony: the dose, the visions, the breakthrough. This episode goes somewhere else. Sand Symes has spent 45 years supporting women, first as a social worker, then as what she calls a modern medicine woman, and she doesn't talk about psychedelics as a fix. She talks about them as a way back to parts of yourself that got buried decades ago and never fully addressed. In this live recording from Psychedelic Salon at Town Hall Seattle, Sand walks through Internal Family Systems, the neuroscience of fear memory, the "trauma of overdoing" that hides inside high-functioning women, and why psychedelic integration for women is the part almost everyone underestimates. If you've ever wondered what actually happens after the journey ends, this is that conversation.

🔵 Key Takeaways

Internal Family Systems (IFS), developed by therapist Richard Schwartz, treats the mind as made up of protector parts, exiled parts carrying old pain, and a calm core self underneath. It's a mainstream therapy model, not something invented by the psychedelic space, though psychedelics often make those parts easier to access directly.

The amygdala stores fear memory and drives the fight, flight, or freeze response before conscious thought catches up. Sand's description of medicine "lulling it to sleep" tracks with established neuroscience on how old memories can be revisited without the same emotional charge.

The "trauma of overdoing" doesn't look like trauma. It looks like competence: the woman managing her career, her household, her aging parents, and everyone else's emotional temperature, who gets praised the entire way for never stopping.

Integration, not the ceremony itself, is where the actual change takes root. Early research on post-psychedelic neuroplasticity is strongest in animal studies so far, but the pattern across integration therapists is consistent: the days and weeks after a journey are when new behavior is easiest to install.

Community and ancestral wisdom show up as recurring threads for women in this work, both as ways of processing suppression carried across generations and as safeguards against re-entering ceremony without adequate support afterward.

🔵 Guest

Sand Symes is a psychedelic guide and integration therapist who has spent 45 years supporting women, first as a social worker and now as what she calls a modern medicine woman. She has sat in over 150 ceremonies, assisted in 70, and facilitated more than 60, working primarily with psilocybin and her own ancestral Celtic lineage rather than ayahuasca, MDMA, or LSD.

Follow Sand Symes: website | Instagram

🔵 Resources

Ask April: How Do I Find a Psychedelic Guide? — column on legal access, licensed facilitators, and the Oregon versus Colorado distinction

Internal Family Systems

Psychedelic Salon at Town Hall Seattle

Women in the Wild | small in-person gatherings in Seattle on September 12th, October 3rd, and November 7th

Follow April on Substack

Visit aprilpride.com

Original Substack post: https://aprilpride.substack.com/sand-symes-ancestral-trauma-psychedelic-integration

Hosted by April Pride

IG: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@aprilpridecreates YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠youtube.com/@aprilpridecreates

127. Psilocybin for Anorexia: Inside UCSF's Trial

Dr. Amanda Downey on UCSF's psilocybin trial for anorexia, why caregivers enroll, and what the medicine can and can't reach in eating disorders.

Episode Summary

Eating disorders are the deadliest psychiatric illness we have. Someone in the United States dies of one every 52 seconds, and two of every three people who get conventional treatment never fully recover. Anorexia nervosa has had no new FDA-approved treatment since the 1990s. That is the ground this conversation stands on, and it is why I sat down with Dr. Amanda Downey at Town Hall Seattle. Dr. Downey is a pediatrician and psychiatrist at UCSF and a lead investigator on an active Phase 2 trial studying psilocybin for anorexia in young adults. We talk about why her trial enrolls caregivers as participants, what psilocybin might reach that decades of treatment have not, and where the science is still honestly uncertain. This one is close to me. I recovered from anorexia myself, and I know how little the map has changed.

🔵 Key Takeaways

Psilocybin is being studied as the first potential breakthrough for anorexia in a generation, but every honest researcher in the room is holding equipoise, not hype. The molecule is one component of a system, not a cure.

The trial's design is unusually intensive because the population is unusually vulnerable. Two high-dose sessions, three preparation sessions before each, real-time heart monitoring, and blood draws throughout. Between 8 and 20 weeks of contact per participant.

Families are part of the treatment. Young people rarely get better if they return to the same system in which the illness grew, so caregivers enroll and prepare too.

Improving cognitive flexibility does not guarantee behavior change. People report expanded thinking and a better quality of life. Whether that translates to weight restoration is the open question this trial is built to answer.

Access without support is the real risk. Psilocybin floods the body with sensation, and people with anorexia are often profoundly disconnected from the body. Unsupported, that experience can compound harm rather than heal it.

🔵 Guest

Dr. Amanda Downey is a pediatrician and psychiatrist specializing in adolescents and young adults with eating disorders. She is the assistant medical director of the UCSF Eating Disorders Program, a member of UCSF’s Translational Psychedelic Research Program, and a lead investigator on an active Phase 2 trial of psilocybin therapy for young adults with anorexia nervosa, ages 18 to 25.

Learn more about UCSF psilocybin and anorexia trial @ clinicaltrials.ucsf.edu

🔵 Resources

Ask April: How Do I Find a Psychedelic Guide? — column on legal access, licensed facilitators, and the Oregon versus Colorado distinction

Original Substack post: https://aprilpride.substack.com/psilocybin-for-anorexia-ucsf-trial

Hosted by April Pride

⁠Follow ⁠⁠April on Substack⁠

IG: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@aprilpridecreates / YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠youtube.com/@aprilpridecreates

Get full access to APRIL PRIDE at aprilpride.com

126. Psychedelics & Addiction: What the Research Shows

Addiction psychiatrist Dr. Nathan Sackett on psilocybin, ibogaine, MDMA, ketamine, and what psychedelic-assisted therapy can and cannot do for substance use disorder.

Episode Summary

The conversation about psychedelics as addiction treatment is moving faster than the research. Dr. Nathan Sackett is trying to close that gap. Founding director of the Center for Novel Therapeutics at the University of Washington, Sackett is an addiction psychiatrist who still sees patients — which matters, because every study his center runs is rooted in clinical reality, not advocacy optics. In this live recording from the Psychedelic Salon at Town Hall Seattle, we cover what the evidence actually supports, what compounds carry genuine risk, and why the most important variable in treatment outcomes may not be the drug at all. If you've been following psychedelic news and want a clearer picture of what's real, this is the conversation.

🔵 Key Takeaways

Psilocybin works as an accelerant, not a cure. It amplifies therapeutic work already in progress — which means the therapeutic work has to be there first.

Ibogaine's cardiac risk is real and cannot be fully predicted even in pre-screened patients. Clinical monitoring with a cardiologist present is not optional — it is the protocol.

Ketamine is habit-forming in a way classic psychedelics are not. Since the pandemic, Dr. Sackett has seen a meaningful rise in ketamine use disorder in his clinical practice.

The variation in long-term outcomes across psilocybin trials may have more to do with integration therapy than with the drug. The field does not yet have standardized integration protocols.

Kratom is available at corner stores and gas stations nationwide and contains a compound with opiate-like properties roughly ten times more potent than morphine. It is undersupported in the research literature and underrecognized as a dependence risk.

🔵 Guest

Dr. Nathan Sackett is an addiction psychiatrist and the founding director of the Center for Novel Therapeutics at the University of Washington, where he leads clinical research at the intersection of psychedelic-assisted therapy, trauma, and substance use disorder. He sees patients in both an addictions clinic and UW's Psychedelic Education and Harm Reduction Clinic.

Dr. Sackett on LinkedIn

Center for Novel Therapeutics, University of Washington

🔵 Resources

#46 Cultivating the Witness with Natasha Lannerd — on metacognition, integration, and the internal observer that makes psychedelic work stick

#117 Ibogaine Treatment at Beond — a conversation with the co-founders of the Mexico-based clinic whose cardiac data Dr. Sackett is currently studying

Ask April: Q: Does the president's executive order legalize psychedelics? — on the executive order, fast-tracked FDA review, and what access will actually cost patients

⁠Original Substack post: https://aprilpride.substack.com/psychedelics-addiction-research-nathan-sackett

SetSet Psychedelic Cards⁠

⁠Women in the Wild application⁠

Hosted by April Pride

Subscribe for April’s newsletter on Substack at ⁠https://aprilpride.substack.com/subscribe⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

IG: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@aprilpridecreates / YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠youtube.com/@aprilpridecreates⁠

Get full access to APRIL PRIDE at ⁠aprilpride.com⁠

125. The Wise Body: What Women's Hormones, Cycles, and Lived Experience Have to Teach Psychedelic Medicine

Stephanie Karzon Abrams of Galilea on why psychedelic care must account for women's cycles, life stage, and the knowledge that predates clinical trials.

Episode Summary

The research on psychedelics was built around male bodies. Women were treated as a confounding variable — their cycles, hormones, and life stages filtered out of study designs rather than centered in them. The result is a clinical landscape where practitioners are guessing, women are underserved, and the knowledge that has existed for generations in women's bodies and lineages is treated as anecdote rather than data.

Stephanie Karzon Abrams is the co-creator of Galilea and founder of Beyond Consulting, a practice focused on psychedelic-informed female care: what it requires, what the research does and doesn't tell us, and what women's lived experience is already teaching practitioners who are paying attention.

🔵 Key Takeaways

Hormonal landscape will influence a woman's psychedelic experience — but the research is contradictory enough that we cannot yet say with certainty in what direction.

GLP-1 medications slow gastric emptying and interfere with the onset of prodrugs like psilocybin, which must be metabolized into active psilocin in the gut.

The distinction between knowledge and knowing is the foundation of the Wise Body framework. Knowledge can be published and replicated. Knowing is generational, intuitive, lived.

Psychedelic therapy is more like surgery than a prescription. It requires preparation, skilled practitioners, and mandatory aftercare.

We don't yet have adequate data on how diversity, culture, comorbidities, and socioeconomic background affect outcomes. And the ecosystems and communities that hold these medicines are not ready to be scaled.

🔵 Timestamps

- 0:01 Intro & Disclaimer

- 0:18 Welcome & Guest Introduction

- 1:46 Shulgin Farm Event Preview

- 3:09 The Research Gap: Hormones & Psychedelics

- 4:44 Explainer: Serotonin & Glutamate

- 5:58 Contradictory Research Findings

- 8:18 The Structural Problem: Women Excluded from Trials

- 9:51 GALILEA Toolkit & Practitioner Resources

- 11:01 GLP-1 Drugs & Psilocybin Interactions

- 15:35 Explainer: Pro-Drugs & Psilocybin Metabolism

- 17:18 Lived Experience & Cyclical Awareness

- 21:22 The Wise Body: Knowing vs Knowledge

- 29:10 Root Cause, Ketamine & Expectations

- 33:28 Ketamine for Postpartum Depression

- 35:12 Reframing Treatment as Surgery

- 37:51 Access, Equity & Slowing the Rollout

- 44:48 Closing Reflections

- 46:33 Where to Find Steph's Work

🔵 Resources

Stephanie Karzon Abrams | Galilea, Beyond Consulting

Psychedelics & the Whole Self: A Gathering for Womxn

Ep. 33 | Therapeutic Psilocybin Use: Tea, Lemon Tek, and Healing

Original Substack post: https://aprilpride.substack.com/women-hormones-psychedelics-practitioner-education

SetSet Psychedelic Cards⁠

⁠Women in the Wild application⁠

Hosted by April Pride

Subscribe for April’s newsletter on Substack at ⁠https://aprilpride.substack.com/subscribe⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Follow on IG: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@aprilpridecreates / YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠youtube.com/@aprilpridecreates ⁠

Get full access to APRIL PRIDE at ⁠aprilpride.com⁠

124. Psychedelic Integration and Intuition: What Actually Changes After Ayahuasca

Explore psychedelic integration and intuition through ayahuasca, grief, and leadership. What really changes after plant medicine?

Episode Summary

What actually happens after the ceremony ends? In this episode, April sits down with Lizzi Cutler to explore psychedelic integration and intuition beyond the peak experience. From ayahuasca to 5-MeO-DMT, Lizzi shares how plant medicine didn’t “fix” her but instead revealed who she already was. The conversation moves through grief and identity, including the emotional reality of not becoming a mother, and expands into how intuition can be applied in unexpected places like business and leadership. This episode will help you understand how to integrate psychedelic experiences into daily life, trust your intuition, rethink personal growth as an ongoing, nonlinear process.

🔵 Key Takeaways

Psychedelics don’t fix you—they reveal patterns you’re already living inside

True ayahuasca integration happens over years, not days or weeks

Intuition isn’t mystical—it’s a skill that can be applied to leadership and hiring

Grief and identity are deeply intertwined, especially around missed life paths

Intuitive leadership may be the missing link in building aligned teams and cultures

🔵 Timestamps

[00:00] Intro, disclaimer, and April’s context on consciousness + intuition[01:00] Introducing Lizzi Cutler and the theme of integration[02:00] Psychedelics and grief + upcoming salon context[03:00] Lizzi’s early work: yoga, meditation, and intuitive sensing[04:00] Naming subconscious patterns and how change begins[05:00] April’s narration: awareness, observation, and the double slit experiment[06:00] Applying intuition to business, hiring, and leadership[08:00] First ayahuasca invitation and entering ceremony work[09:00] Ayahuasca + San Pedro explained (context + risks)[10:00] First ceremonies: “feeling nothing” and frustration[10:30] Dieta explained: preparation, digestion, and intuition[12:00] First breakthrough experience and community bonding[13:00] Divorce, feeling “broken,” and seeking transformation[14:00] 30–40 ceremonies later: what ayahuasca actually revealed[15:00] “Own your power” and letting go of imitation[16:00] The apprenticeship dynamic + April’s ethical commentary[18:00] Surrendering to intuition and first real validation[19:00] Bringing intuitive work into real-world practice[20:00] Shifting from personal coaching to stress + behavior change[21:00] Breakthrough moment: intuition applied to business[22:00] Alignment, investing, and intuitive due diligence[23:00] Oneness, source, and early 5-MeO insights[24:00] Psychedelics don’t give gifts—they reveal them[25:00] Intuition as a natural ability vs learned skill[26:00] 5-MeO-DMT explained + non-dual awareness[26:30] “I am enough”: the end of the “I’m broken” narrative[27:00] Embodiment, love, and kintsugi (wholeness through integration)[28:00] Integration over time + relationships and emotional growth[29:00] Building an intuitive business model (CEO-focused work)[30:00] “Intuitive analysis” and reading organizational culture[31:00] AI vs intuition: human pattern recognition[32:00] Leadership decisions, restructuring, and team alignment[33:00] Working with investors, philanthropy, and impact[34:00] Money as energy + alignment in giving[35:00] Closing reflections + where this work is going[36:00] Outro + resources + psychedelic grief salon

🔵 Resources

Original Microdosing for Midlife Substack post: https://aprilpride.substack.com/p/psychedelic-integration-and-intuition-ayahuasca-leadership

⁠SetSet Psychedelic Cards⁠

⁠Women in the Wild application⁠

Hosted by April Pride

Subscribe for April’s newsletter on Substack at ⁠https://aprilpride.substack.com/subscribe⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Follow on IG: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@aprilpridecreates / YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠youtube.com/@aprilpridecreates ⁠

Get full access to APRIL PRIDE at ⁠aprilpride.com⁠

123. Microdosing for Midlife: Emotional Resilience(Week 6)

Week 6 explores extinction learning, emotional resilience, and how microdosing may support gradual rewiring of fear-based patterns in midlife.

Episode Summary

This episode is part Week 6 of Microdosing for Midlife—a 12-part audio companion to the original Substack series.

In this conversation, April explores emotional resilience not as toughness or avoidance, but as the ability to update old responses in real time. Using entrepreneurship as metaphor, she reflects on how repeated attempts, setbacks, and recalibration build resilience—and how microdosing psilocybin intersects with that process.

The episode introduces the neuroscience concept of extinction learning—the brain’s ability to replace outdated fear responses with more informed ones. Rather than positioning microdosing as a cure or shortcut, April frames it as a catalyst for noticing habitual reactions, pausing before reenactment, and building new neural pathways through integration.

If the written post focused on the science and story, this episode explores how resilience is practiced—not performed—especially in midlife when old coping strategies no longer serve.

🔵 Key Takeaways

What extinction learning means in practical terms

How emotional resilience differs from emotional suppression

Why microdosing is described as a catalyst—not a quick fix

The role of integration in reinforcing new neural pathways

How midlife transitions resurface habitual responses

Why subtle shifts often matter more than dramatic breakthroughs

One reflection to carry into the week ahead

🔵 Timestamps

[00:00] Episode opening[02:00] Entrepreneurship and resilience as metaphor[04:30] Extinction learning explained[07:00] Personal example of breaking habitual responses[10:00] Integration and grounding practices[13:00] Midlife transitions and emotional awareness[16:00] What to carry forward

🔵 Resources

Original Microdosing for Midlife Substack post: https://aprilpride.substack.com/p/microdosing-psilocybin-for-emotional-resilience

⁠SetSet Psychedelic Cards⁠

⁠Women in the Wild application⁠

Hosted by April Pride

Subscribe for April’s newsletter on Substack at ⁠https://aprilpride.substack.com/subscribe⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Follow on IG: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@aprilpridecreates / YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠youtube.com/@aprilpridecreates ⁠

Get full access to APRIL PRIDE at ⁠aprilpride.com⁠

122. Microdosing for Midlife: Stability & Nervous System Change (Week 5)

Week 5 explores masking, authenticity, the Default Mode Network, and how microdosing may soften rigid self-narratives in midlife.

Episode Summary

This episode is part Week 5 of Microdosing for Midlife—a 12-part audio companion to the original Substack series.

In this conversation, April explores authenticity not as a dramatic revelation, but as a gradual unmasking. Rather than chasing peak experiences or forced breakthroughs, she reflects on how microdosing intersects with identity, ego softening, and the quiet recognition of truths long postponed. The episode examines the difference between escape and exposure—and why midlife often demands something more sustainable than either.

Drawing from neuroscience, lived experience, and even a bridge to quantum physics, April considers how the Default Mode Network (DMN) reinforces self-stories—and how gentle disruptions may create space for new ones. This is not about dramatic ego dissolution. It’s about noticing the yes that’s actually a no, the roles we’ve outgrown, and the parts of ourselves we’ve hidden to stay acceptable.

If you’ve read the original essay, this episode deepens it. If you haven’t, it stands on its own—and may send you back to read more closely.

🔵 Key Takeaways

How “masking” functions psychologically and neurologically

The role of the Default Mode Network in identity and self-story

Why escape and authenticity are often confused

How microdosing may soften rigid self-narratives

The difference between forced revelation and sustained alignment

What flow actually represents in midlife transition

One reflection to carry into the week ahead

🔵 Timestamps

[00:00] Episode opening[02:00] Masking, escape, and authenticity[05:00] A personal mask-off moment[07:00] Default Mode Network and ego narratives[10:00] Observation and identity[13:00] Flow and sustained alignment[15:00] What to carry forward

🔵 Resources

Original Microdosing for Midlife Substack post: https://aprilpride.substack.com/p/microdosing-for-authenticity

⁠SetSet Psychedelic Cards⁠

⁠Women in the Wild application⁠

Hosted by April Pride

Subscribe for April’s newsletter on Substack at ⁠https://aprilpride.substack.com/subscribe⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Follow on IG: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@aprilpridecreates / YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠youtube.com/@aprilpridecreates ⁠

Get full access to APRIL PRIDE at ⁠aprilpride.com⁠

121. Microdosing for Midlife: Stability & Nervous System Change (Week 4)

Week 4 of Microdosing for Midlife explores how nervous system stability shapes identity, growth, and long-term change in midlife.

Episode Summary

This episode is part Week 4 of Microdosing for Midlife—a 12-part audio companion to the original Substack series.

In this conversation, April expands on what it actually means to feel stable while undergoing change. Midlife often brings visible transitions—shifts in hormones, identity, relationships, ambition—but underneath those external markers is something quieter: the nervous system recalibrating itself. Rather than focusing on dramatic breakthroughs, this episode examines how safety, steadiness, and subtle internal shifts create sustainable growth.

Instead of chasing intensity, April reflects on how microdosing can support capacity—capacity to tolerate discomfort, to remain present in uncertainty, and to integrate insight gradually. The real work is not in peak moments. It’s in the ability to return to baseline without abandoning yourself.

🔵 Key Takeaways

How nervous system stability shapes long-term growth in midlife

Why intensity is often mistaken for progress

How subtle shifts accumulate into meaningful identity change

What “capacity building” looks like beyond insight

A reflection question to carry into the week ahead

🔵 Timestamps

[00:00] Episode opening[02:00] Framing the week’s theme[08:30] Nervous system stability vs intensity[15:00] Capacity building in midlife[22:00] Integration reflection[27:00] What to carry forward

🔵 Resources

⁠⁠SetSet Psychedelic Cards⁠

⁠Women in the Wild application⁠

Hosted by April Pride

Subscribe for April’s newsletter on Substack at ⁠https://aprilpride.substack.com/subscribe⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Follow on IG: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@aprilpridecreates / YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠youtube.com/@aprilpridecreates ⁠

Get full access to APRIL PRIDE at ⁠aprilpride.com⁠